Related references
Note: Only part of the references are listed.Design and Development of Biomimetic Nanovesicles Using a Microfluidic Approach
Roberto Molinaro et al.
ADVANCED MATERIALS (2018)
Biomimetic nanoparticles with enhanced affinity towards activated endothelium as versatile tools for theranostic drug delivery
Jonathan O. Martinez et al.
THERANOSTICS (2018)
Price tag in nanomaterials?
D. A. Gkika et al.
JOURNAL OF NANOPARTICLE RESEARCH (2017)
Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery
Alessandro Parodi et al.
BIOMATERIALS (2017)
Chlorin e6 Functionalized Theranostic Multistage Nanovectors Transported by Stem Cells for Effective Photodynamic Therapy
Simo Nakki et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Challenges and strategies in anti-cancer nanomedicine development: An industry perspective
Jennifer I. Hare et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Electroporation and lipid nanoparticles with cyanine IR-780 and flavonoids as efficient vectors to enhanced drug delivery in colon cancer
Julita Kulbacka et al.
BIOELECTROCHEMISTRY (2016)
Cell source determines the immunological impact of biomimetic nanoparticles
Michael Evangelopoulos et al.
BIOMATERIALS (2016)
One-pot synthesis of pH-responsive hybrid nanogel particles for the intracellular delivery of small interfering RNA
Sm Z. Khaled et al.
BIOMATERIALS (2016)
Role of Adjuvant Therapy in a Population-Based Cohort of Patients With Early-Stage Small-Cell Lung Cancer
Chi-Fu Jeffrey Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Respiratory toxicity and immunotoxicity evaluations of microparticle and nanoparticle C60 fullerene aggregates in mice and rats following nose-only inhalation for 13 weeks
Brian C. Sayers et al.
NANOTOXICOLOGY (2016)
Biomimetic proteolipid vesicles for targeting inflamed tissues
R. Molinaro et al.
NATURE MATERIALS (2016)
Drug-loaded erythrocytes: on the road toward marketing approval
Vanessa Bourgeaux et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Biomimetic carriers mimicking leukocyte plasma membrane to increase tumor vasculature permeability
R. Palomba et al.
SCIENTIFIC REPORTS (2016)
Enhanced efficacy of chemotherapy for breast cancer stem cells by simultaneous suppression of multidrug resistance and antiapoptotic cellular defense
Ming Sun et al.
ACTA BIOMATERIALIA (2015)
Macrophage mediated biomimetic delivery system for the treatment of lung metastasis of breast cancer
Jijun Fu et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Physicochemical properties affect the synthesis, controlled delivery, degradation and pharmacokinetics of inorganic nanoporous materials
Iman K. Yazdi et al.
NANOMEDICINE (2015)
Cost-effectiveness of nanomedicine: the path to a future successful and dominant market?
Rita Bosetti
NANOMEDICINE (2015)
Nanotherapeutics in the EU: an overview on current state and future directions
Anita Hafner et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2014)
State-of-the-art in design rules for drug delivery platforms: Lessons learned from FDA-approved nanomedicines
Charlene M. Dawidczyk et al.
JOURNAL OF CONTROLLED RELEASE (2014)
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
Hiroshi Maeda et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Pharmacokinetic considerations for targeted drug delivery
Fumiyoshi Yamashita et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Cancer heterogeneity: implications for targeted therapeutics
R. Fisher et al.
BRITISH JOURNAL OF CANCER (2013)
Microfluidic electroporation for cellular analysis and delivery
Tao Geng et al.
LAB ON A CHIP (2013)
Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions
Alessandro Parodi et al.
NATURE NANOTECHNOLOGY (2013)
Short and Long Term, In Vitro and In Vivo Correlations of Cellular and Tissue Responses to Mesoporous Silicon Nanovectors
Jonathan O. Martinez et al.
SMALL (2013)
Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor
Yinghuan Li et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine
Xue-Qing Zhang et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Adherence to adjuvant therapy in post-menopausal breast cancer patients: a review
M. Banning
EUROPEAN JOURNAL OF CANCER CARE (2012)
The effect of particle size on the biodistribution of low-modulus hydrogel PRINT particles
Timothy J. Merkel et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Designing the nanoparticle-biomolecule interface for targeting and therapeutic delivery
Eugene Mahon et al.
JOURNAL OF CONTROLLED RELEASE (2012)
The journey of a drug-carrier in the body: An anatomo-physiological perspective
Nicolas Bertrand et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities
Zhiliang Cheng et al.
SCIENCE (2012)
The analysis of doxorubicin resistance in human breast cancer cells using antibody microarrays
Laura Smith et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Nanoparticle and targeted systems for cancer therapy
L Brannon-Peppas et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms -: Intermediacy of H2O2- and p53-dependent pathways
SW Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Share Paper
